Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in LRMR — Larimar Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to LRMR Full portfolio

Position in LRMR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$189,414
+$98,388 QoQ
Shares Held
62,103
+207.0% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 163 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. LRMR ranks #254 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in LRMR

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $189,414 62,103
2026-03-31 $91,026 20,228
2025-12-31 $216,777 56,897
2025-09-30 $124,160 38,440
2025-06-30 $85,424 29,559
2025-03-31 $48,362 22,494
2024-12-31 $76,072 19,657
2024-09-30 $84,861 12,956
2024-06-30 $97,650 13,469
2024-03-31 $71,558 9,428
2023-12-31 $36,377 7,995
2023-09-30 $25,398 6,430
2023-06-30 $30,658 9,795
2023-03-31 $906 200
2022-12-31 $813 197
2022-09-30 $313 98
2022-06-30 $152 78
2020-12-31 $119,980 5,604
2020-09-30 $1,198 79
2020-06-30 $205 16